Acromegaly News and Research

RSS
Acromegaly is a syndrome that results when the pituitary gland produces excess growth hormone (hGH) after epiphyseal plate closure at puberty.
Research report on current and evolving technologies in drug delivery

Research report on current and evolving technologies in drug delivery

Novartis' SOM230 reduces cortisol levels in Cushing's disease patients

Novartis' SOM230 reduces cortisol levels in Cushing's disease patients

Ipsen 2010 first half revenue increases to €31.7 million

Ipsen 2010 first half revenue increases to €31.7 million

World's tallest man undergoes Gamma Knife surgery

World's tallest man undergoes Gamma Knife surgery

FDA grants orphan drug designation for Chiasma's Octreolin

FDA grants orphan drug designation for Chiasma's Octreolin

Chiasma successfully completes Phase I clinical study of Octreolin

Chiasma successfully completes Phase I clinical study of Octreolin

Researchers evaluate efficacy of GKRS in patients with pituitary adenoma

Researchers evaluate efficacy of GKRS in patients with pituitary adenoma

Ipsen's first-quarter 2010 drug sales up 6.2%

Ipsen's first-quarter 2010 drug sales up 6.2%

Invida to distribute and promote Ipsen's Diphereline, Somatuline Autogel and Increlex in South-East Asia

Invida to distribute and promote Ipsen's Diphereline, Somatuline Autogel and Increlex in South-East Asia

Highlights from AACE 19th Annual Meeting and Clinical Congress

Highlights from AACE 19th Annual Meeting and Clinical Congress

Minimally invasive technique holds promise for removing large brain tumors

Minimally invasive technique holds promise for removing large brain tumors

Ipsen commences dosing in two BIM 23A760 phase II studies for neuroendocrine tumors and acromegaly

Ipsen commences dosing in two BIM 23A760 phase II studies for neuroendocrine tumors and acromegaly

PAN to provide co-payment assistance for medications to underinsured patients through five new funds

PAN to provide co-payment assistance for medications to underinsured patients through five new funds

Ipsen announces sales highlights for the first nine months of 2009

Ipsen announces sales highlights for the first nine months of 2009

Antisense Therapeutics completes repeat-dosing toxicology studies for ATL1103

Antisense Therapeutics completes repeat-dosing toxicology studies for ATL1103

Discovery of mutation in AIP gene associated with acromegaly

Discovery of mutation in AIP gene associated with acromegaly

Indevus Pharmaceuticals enters merger agreement with Endo Pharmaceuticals

Indevus Pharmaceuticals enters merger agreement with Endo Pharmaceuticals

Endo Pharmaceuticals to acquire Indevus Pharmaceuticals

Endo Pharmaceuticals to acquire Indevus Pharmaceuticals

Gleevec receives FDA priority review for gastrointestinal stromal tumors after surgery

Gleevec receives FDA priority review for gastrointestinal stromal tumors after surgery

Human growth hormone abuse raises serious health risks

Human growth hormone abuse raises serious health risks